Opportunity Information: Apply for RFA MH 20 400
The National Institutes of Health (NIH) released this discretionary grant funding opportunity (RFA-MH-20-400; CFDA 93.242) to support research on how to successfully implement and sustain evidence-based mental health practices in low-resource, under-resourced U.S. settings, with the explicit goal of advancing mental health equity for traditionally underserved populations. The core emphasis is not on inventing new treatments, but on figuring out how to get proven, evidence-based mental health treatments and services delivered effectively, consistently, and long term in real-world environments where resources, staffing, infrastructure, and access are limited. The FOA uses the R01 mechanism and is labeled "Clinical Trial Optional," meaning applicants may propose studies that include a clinical trial component, but a trial is not required if the research questions can be addressed through other rigorous designs.
At the center of this FOA is implementation effectiveness: developing and testing strategies that help organizations and communities adopt evidence-based practices (EBPs), deliver them with quality, and keep them going after the study period ends. NIH is looking for research that directly tackles the barriers that often prevent underserved groups from receiving, accessing, engaging in, or benefiting from EBPs, including obstacles on the provider side (for example, lack of trained clinicians, high turnover, limited supervision, workflow constraints), the system side (reimbursement limitations, fragmented services, weak referral pathways, limited data systems), and the patient or community side (transportation, stigma, language barriers, cultural mismatch, mistrust, competing life demands, digital divide). Strong applications are expected to propose innovative and practical approaches to removing or reducing these barriers in ways that fit the realities of low-resource settings.
A major theme is equity-focused implementation. The FOA encourages studies that generate new knowledge about what drives mental health disparities and what reduces them, not only by documenting differences in outcomes but by identifying the mechanisms that create unequal access, unequal quality, or unequal benefit. In practice, that means applicants should pay attention to how implementation choices can widen or narrow disparities, and should measure outcomes in a way that can demonstrate progress toward equity (for example, improved reach into underserved groups, better engagement and retention, reduced symptom burden, improved functioning, fewer crisis events, or improved patient-reported outcomes). The announcement also highlights the importance of considering needs across the life span, so projects may focus on children, adolescents, adults, older adults, or multiple age groups, as long as the work addresses equity in underserved populations.
The eligible applicant pool is broad and includes many types of U.S.-based organizations and governments. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities. The FOA explicitly calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions. At the same time, there are clear restrictions related to foreign involvement: non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed under this opportunity.
Administratively, the funding instrument is a grant under the health activity category, sponsored by NIH. The opportunity was created on November 27, 2019, and the original closing date listed is August 25, 2020. The public summary does not provide an award ceiling or the expected number of awards, so applicants would typically need to consult the full FOA text for budget guidance, project period limits, and any institute-specific priorities or review criteria. Overall, the opportunity is aimed at producing actionable, generalizable evidence about how to implement and sustain high-quality, evidence-based mental health care in places where it is hardest to do so, and to do it in a way that measurably reduces inequities experienced by underserved populations in the United States.Apply for RFA MH 20 400
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2019-11-27.
- Applicants must submit their applications by 2020-08-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed)
Previous opportunity: Real Time Chromatin Dynamics and Function (U01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 20 400
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 20 400) also looked into and applied for these:
| Funding Opportunity |
|---|
| Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed) Apply for PAR 20 066 Funding Number: PAR 20 066 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 20 001 Funding Number: RFA RM 20 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trial Not Allowed) Apply for RFA RM 20 002 Funding Number: RFA RM 20 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Mentored Research Scientist Career Development Award (K01) Apply for PA 20 067 Funding Number: PA 20 067 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Improving Quality of Care and Patient Outcomes During Care Transitions (R01) Apply for PA 20 068 Funding Number: PA 20 068 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Immune Tolerance Network (UM1 Clinical Trial Required) Apply for RFA AI 19 068 Funding Number: RFA AI 19 068 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) Apply for PAR 20 071 Funding Number: PAR 20 071 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional) Apply for PAR 20 070 Funding Number: PAR 20 070 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Dental Practice-Based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) Apply for PAR 20 073 Funding Number: PAR 20 073 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Apply for PAR 20 072 Funding Number: PAR 20 072 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Predoctoral to Postdoctoral Transition Award for A Diverse Dental, Oral, and Craniofacial Research Workforce (F99/K00 Clinical Trial Not Allowed) Apply for PAR 20 069 Funding Number: PAR 20 069 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CATALYTIC CHANGE FOR CROSS BORDER HEALTH Apply for RFI 720 623 001 Funding Number: RFI 720 623 001 Agency: Kenya USAID-Nairobi Category: Health Funding Amount: $10,000,000 |
| Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R21 Clinical Trial Not Allowed) Apply for RFA MH 20 331 Funding Number: RFA MH 20 331 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R01 Clinical Trial Optional) Apply for RFA MH 20 330 Funding Number: RFA MH 20 330 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed) Apply for RFA AG 21 010 Funding Number: RFA AG 21 010 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed) Apply for RFA AG 21 002 Funding Number: RFA AG 21 002 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) Apply for RFA AI 19 072 Funding Number: RFA AI 19 072 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 20 078 Funding Number: PAR 20 078 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition 4DN Data Coordination and Integration Center (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 008 Funding Number: RFA RM 20 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: 4DN Organizational Hub (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 007 Funding Number: RFA RM 20 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 20 400", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
